Phathom Pharmaceuticals (NASDAQ:PHAT) traded higher on Friday after Cantor Fitzgerald initiated its coverage with an overweight recommendation despite a recent selloff attributed to the company's IP ...

Tom Homan as border czar: A former New York police officer, Homan’s appointment as “border czar” wasn’t much of a surprise – ...

As previously reported last night, Cantor Fitzgerald initiated coverage of five Government Technology & Space, or “GovTech,” stocks, ...

Alongside record profits, USDT issuer Tether also reported Friday it now holds over $143 billion in reserve assets to back ...

India and China have the most tariffs but no inflation, an American businessman nominated by President Donald Trump to be his commerce secretary told lawmakers, emphasising that there is no ...

On Friday, Cantor Fitzgerald reaffirmed its Overweight rating on Cipher Mining shares (NASDAQ:CIFR), with a set price target of $11.00. The firm's analyst, Brett Knoblauch, provided insight into ...

In a report released yesterday, C J Muse from Cantor Fitzgerald maintained a Hold rating on KLA (KLAC – Research Report), with a price target of $875.00. The company’s shares closed yesterday ...

Some pundits seriously doubt whether Atlanta Braves free agent signing Jurickson Profar can repeat his breakout 2024 campaign. But for right now, he's among the best players in baseball. MLB ...

Cantor Fitzgerald LP ’s lawsuit alleging a firm founded by four of its former investment bankers stole clients worth millions of dollars in profit was dismissed by a New York judge. Justice Nancy ...

Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from Neutral to Overweight. As of January 29, 2025, the average one-year ...